Nahid Karamzad
Overview
Explore the profile of Nahid Karamzad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Safiri S, Nejadghaderi S, Karamzad N, Kaufman J, Carson-Chahhoud K, Bragazzi N, et al.
Front Endocrinol (Lausanne)
. 2022 Aug;
13:879890.
PMID: 35966097
Background: To report the burden of cancers attributable to high fasting plasma glucose (HFPG) by sex, age, location, cancer type and Socio-demographic Index (SDI) over the period 1990 to 2019...
12.
Safiri S, Noori M, Nejadghaderi S, Karamzad N, Carson-Chahhoud K, Sullman M, et al.
Hum Reprod
. 2022 May;
37(8):1919-1931.
PMID: 35586937
Study Question: What is the global, regional and national burden of polycystic ovary syndrome (PCOS), by age and socio-demographic index (SDI), over the period 1990-2019? Summary Answer: In 2019, the...
13.
Karamzad N, Faraji E, Adeli S, Sullman M, Pourghassem Gargari B
Nutr Diabetes
. 2022 Apr;
12(1):15.
PMID: 35365594
Background: Type 2 diabetes mellitus (T2DM) is a common disorder that is characterized by chronic hyperglycemia and chronic inflammation, which also have a reinforcing effect on each other. The present...
14.
Safiri S, Karamzad N, Kaufman J, Bell A, Nejadghaderi S, Sullman M, et al.
Front Endocrinol (Lausanne)
. 2022 Mar;
13:838027.
PMID: 35282442
Aim: To report the point prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories during the period 1990-2019. Methods:...
15.
Safiri S, Nejadghaderi S, Karamzad N, Carson-Chahhoud K, Bragazzi N, Sullman M, et al.
Cancer
. 2022 Mar;
128(9):1840-1852.
PMID: 35239973
Background: Alcohol consumption is a risk factor for a number of communicable and non-communicable diseases, including several types of cancer. This article reports the burden of cancers attributable to alcohol...
16.
Safiri S, Karamzad N, Kaufman J, Nejadghaderi S, Bragazzi N, Sullman M, et al.
Obesity (Silver Spring)
. 2022 Jan;
30(2):535-545.
PMID: 35041300
Objective: The aim of this study was to report the level and trends of 13 cancers that are attributable to excess body weight (EBW) for 204 countries and territories from...
17.
Safiri S, Karamzad N, Singh K, Carson-Chahhoud K, Adams C, Nejadghaderi S, et al.
Eur J Prev Cardiol
. 2021 Dec;
29(2):420-431.
PMID: 34922374
Aims: To report the prevalence, deaths, and disability-adjusted life years (DALYs) associated with ischemic heart disease (IHD) and its attributable risk factors in 204 countries and territories from 1990 to...
18.
Safiri S, Kolahi A, Noori M, Nejadghaderi S, Karamzad N, Bragazzi N, et al.
J Hematol Oncol
. 2021 Nov;
14(1):185.
PMID: 34736513
Background: Anemia is a common disease which affects around 40% of children and 30% of reproductive age women and can have major health consequences. The present study reports the global,...
19.
Safiri S, Carson-Chahhoud K, Karamzad N, Sullman M, Nejadghaderi S, Taghizadieh A, et al.
Chest
. 2021 Oct;
161(2):318-329.
PMID: 34699773
Background: Understanding global trends in the point prevalence, deaths, and disability-adjusted life-years (DALYs) for asthma will facilitate evidence-based decision-making. Research Question: What are the global, regional, and national burdens of...
20.
Karamzad N, Izadi N, Sanaie S, Ahmadian E, Eftekhari A, Sullman M, et al.
J Cardiovasc Thorac Res
. 2020 Jul;
12(2):120-128.
PMID: 32626552
This study aimed to perform a meta-analysis on the prevalence of metabolic syndrome (MetS) among patients with asthma and to measure the association asthma has with MetS. The Web of...